Thank you.
We don't allow a pharmaceutical to hit the market unless the Department of Health has signed off on it, yet we allow a security to hit the market based upon a rating produced by a company that is dependent upon the issuers of those securities for its revenues.
Does that strike you as a very serious flaw in our system?